Opinion: Vaccine for malaria took a while, but it’s worth the wait
By K. Leelamoni January 16, 2024: Vaccination is a simple, safe and effective method of protecting the body against infectious diseases. Ever since.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
By K. Leelamoni January 16, 2024: Vaccination is a simple, safe and effective method of protecting the body against infectious diseases. Ever since.
HQ Team December 21, 2023: The World Health Organization has added a second malaria vaccine to its list of prequalified vaccines to enable.
HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.
The World Health Organization has recommended a second vaccine for the prevention of malaria in children to overcome a shortage of medicine, particularly in.
HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.
HQ Team July 10, 2023: US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria..
HQ Team July 6, 2023: The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first.
HQ Team June 27, 2023: For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states,.
HQ Team April 19, 2023: The WHO called on Sudan’s warring factions to refrain from attacks on healthcare personnel, as about 270 people.
BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with.